RAISE Act
Summary
Renal Anemia Innovation Support and Expansion Act or the RAISE Act This bill allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2021
Committee Review
Floor Vote
President
Introduced Apr 30, 2021
Last action May 3, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
0
Committee
4
May 3, 2021
Committee
Referred to the Subcommittee on Health.
lower
Apr 30, 2021
Committee
Referred to the Subcommittee on Health.
lower
Apr 30, 2021
Committee
Referred to the Subcommittee on Social Security.
lower
Apr 30, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 30, 2021
Introduced
Introduced in House
lower
1 primary · 6 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 2934
Scope: US
Hi! I can help you understand HR 2934. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline